Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;1(4):691-695.
doi: 10.3892/ol_00000121. Epub 2010 Jul 1.

Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma

Affiliations

Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma

Cheng-Keng Chuang et al. Oncol Lett. 2010 Jul.

Abstract

We investigated the matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) proteins in transitional cell carcinoma (TCC) cell lines and surgical specimens of the bladder neoplasm. The expression level was correlated to the degree of cellular differentiation and invasiveness of bladder cancer. Panels of six TCC cell lines with different degrees of differentiation were tested with monoclonal antibodies (mAbs) to MMP-1, MMP-2, MMP-3, MMP-9a, MMP-9b, TIMP-1 and TIMP-2 by immunocytochemistry. Gelatin zymography was also conducted on the cell lines for MMP-2 and -9. In addition, immunohistochemistry with the mAbs to MMP and TIM molecules was performed on 30 TCC specimens. We found that TCC cell lines were stained positively for MMP-1 (6/6), weakly for MMP-9a (2/6), MMP9b (5/6) and TIMP-1 (3/6), and negatively for MMP-2 (3/6) and MMP-3 (3/6). Zymographic analysis of the cell lines showed a high level of MMP2 in the MGH-U4 cell line. In bladder cancer surgical specimens, all specimens were positive for MMP1 (30/30), 19 were positive for MMP-2 (63.3%), 21 positive for MMP-9a (70%) and 15 positive for MMP-9b (50%). The expression of MMP-2 was found to be positively correlated with higher-grade tumors (p=0.036) and the expression of MMP-9a and -9b was found to be positively correlated with tumor stage (p=0.012 and 0.023, respectively). However, the expression of MMP-1, MMP-3, TIMP-1 and TIMP-2 was not correlated with either tumor staging or grading. In conclusion, the expression of MMP-2 and -9 was correlated with high-grade or high-stage bladder tumors, respectively. However, this correlation was not observed with TCC cell lines in which high- and low-grade tumors are included. Immunohistochemical results on tumor lesions may have more clinical relevance, since in a given tumor microenvironment the interaction among tumor cells in situ and tumor-associated cells, such as neutrophils, macrophages, lymphocytes and endothelial cells, as well as environmental factors (hypoxia and pH), cytokines and growth factors released by these cells may be required for TCC to express selective MMPs and TIMPs. The selective expression of these molecules then regulates tumor progression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gelatin zymographic analysis of MMP-2 and -9 in the condition media of six cultured TCC cell lines at days 1, 3 and 5 (A) and quantification of their activities after subtraction of background values (medium control) (B). In (B), the black bar is MMP-2 with a molecular mass of 72 kDa, the dark grey bar is MMP-9 with a molecular mass of 84 kDa and the light grey bar is pro-MMP-9 with a molecular mass of 92 kDa.

Similar articles

Cited by

References

    1. Liotta LA. Tumor invasion and metastasis: role of the extracellular matrix. Cancer Res. 1986;46:1–7. - PubMed
    1. Chuang CK, Liao SK. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinoma. Anticancer Res. 2003;23:4635–4640. - PubMed
    1. Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990;50:6184–6191. - PubMed
    1. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettline C, Menck HR. The national cancer data base report on bladder carcinoma. Cancer. 1996;77:1505–1513. - PubMed
    1. Chuang CK, Liao SK. Evaluation of CA19-9 as a tumor marker in urothelial malignancy. Scand J Urol Nephrol. 2004;38:359–365. - PubMed